Early detection remains the best method for reducing breast cancer related deaths.
Together with our Group charity Australian Breast Cancer Research, we are funding research focused on the prevention, detection, management and treatment of breast cancer to improve outcomes for the women we love.
Breast Cancer Support
Identifying a list of new and existing drugs which show promise in changing an offending hormone receptor in breast cancer from cancer-promoting to cancer-inhibiting.
Progressing research into a protein called Creld2 which causes breast cancer to develop and grow more quickly, with work now turning to finding agents to destroy or block this protein and offer alternative pathways to treat aggressive breast cancer.
Investigating breast cancer cells which become resistant to chemotherapy, focusing on a little-known protein called Basconuclin-2 which may hold clues to help treat cancer cells which are prone to relapse or capable of re-seeding other types of tumour cells.
Investigating ways to slow, stop or reverse the effects of a newly-found compression force experienced by rapidly growing cancer cells, to help stop breast cancer metastasis (spread).
Improving the diagnosis of triple negative breast cancer by investigating whether a previously unstudied protein can diagnose this aggressive and deadly form of the disease sooner and also provide a better treatment option.
Helping women get the best of their breast cancer treatment and avoid harmful drug interactions if they are also taking other medications, particularly in regards to blood pressure and cholesterol lowering drugs.
Improving breast cancer screening outcomes for women with dense breasts through increased education about high breast density.
Exploring a number of different inhibitors which show promise in blocking a protein called Aquaporin 1, which has been proven to play a key role in helping breast cancer cells moving to other parts of the body.